ISSN 2394-5125
 

Review Article 
JCR. 2014; 1(1): 25-28


A REVIEW ON IRBESARTAN CO ADMINISTERED WITH ATORVASTATIN FOR THE TREATMENT OF CARDIAC RISK

PARAS VIRANI, RAJANIT SOJITRA, HASUMATI RAJ, VINEET JAIN.

Abstract
Hypertension and Hypercholesterolemia are a major public health problem in the developed Countries recently. Hypertension and hypercholesterolemia are frequently treated with antihypertensive drugs like calcium-channel blockers, angiotensin-converting enzyme inhibitors, and angiotensinII (AT1) receptor blockers, and statins. Irbesartan is angiotensin II receptor type 1 antagonist and widely used in treatment of hypertension condition. Atorvastatin is HMG CoA reductase inhibitor and widely used in treatment of hyper lipidaemias condition. .Combination of irbesartan and atorvastatin is used in the treatment of cardiovascular diseases like hypertension and hyper lipidemias. So this combination therapy gives antihypertensive and antilipidemic effects in the treatment of coronary artery diseases.

Key words: Irbesartan, Atorvastatin, Antihypertensive, Antilipidemic, Pharmacology, Combination Therapy.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by PARAS VIRANI
Articles by RAJANIT SOJITRA
Articles by HASUMATI RAJ
Articles by VINEET JAIN
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

PARAS VIRANI , RAJANIT SOJITRA, HASUMATI RAJ, VINEET JAIN. A REVIEW ON IRBESARTAN CO ADMINISTERED WITH ATORVASTATIN FOR THE TREATMENT OF CARDIAC RISK. JCR. 2014; 1(1): 25-28.


Web Style

PARAS VIRANI , RAJANIT SOJITRA, HASUMATI RAJ, VINEET JAIN. A REVIEW ON IRBESARTAN CO ADMINISTERED WITH ATORVASTATIN FOR THE TREATMENT OF CARDIAC RISK. http://www.jcreview.com/?mno=302644807 [Access: April 19, 2021].


AMA (American Medical Association) Style

PARAS VIRANI , RAJANIT SOJITRA, HASUMATI RAJ, VINEET JAIN. A REVIEW ON IRBESARTAN CO ADMINISTERED WITH ATORVASTATIN FOR THE TREATMENT OF CARDIAC RISK. JCR. 2014; 1(1): 25-28.



Vancouver/ICMJE Style

PARAS VIRANI , RAJANIT SOJITRA, HASUMATI RAJ, VINEET JAIN. A REVIEW ON IRBESARTAN CO ADMINISTERED WITH ATORVASTATIN FOR THE TREATMENT OF CARDIAC RISK. JCR. (2014), [cited April 19, 2021]; 1(1): 25-28.



Harvard Style

PARAS VIRANI , RAJANIT SOJITRA, HASUMATI RAJ, VINEET JAIN (2014) A REVIEW ON IRBESARTAN CO ADMINISTERED WITH ATORVASTATIN FOR THE TREATMENT OF CARDIAC RISK. JCR, 1 (1), 25-28.



Turabian Style

PARAS VIRANI , RAJANIT SOJITRA, HASUMATI RAJ, VINEET JAIN. 2014. A REVIEW ON IRBESARTAN CO ADMINISTERED WITH ATORVASTATIN FOR THE TREATMENT OF CARDIAC RISK. Journal of Critical Reviews, 1 (1), 25-28.



Chicago Style

PARAS VIRANI , RAJANIT SOJITRA, HASUMATI RAJ, VINEET JAIN. "A REVIEW ON IRBESARTAN CO ADMINISTERED WITH ATORVASTATIN FOR THE TREATMENT OF CARDIAC RISK." Journal of Critical Reviews 1 (2014), 25-28.



MLA (The Modern Language Association) Style

PARAS VIRANI , RAJANIT SOJITRA, HASUMATI RAJ, VINEET JAIN. "A REVIEW ON IRBESARTAN CO ADMINISTERED WITH ATORVASTATIN FOR THE TREATMENT OF CARDIAC RISK." Journal of Critical Reviews 1.1 (2014), 25-28. Print.



APA (American Psychological Association) Style

PARAS VIRANI , RAJANIT SOJITRA, HASUMATI RAJ, VINEET JAIN (2014) A REVIEW ON IRBESARTAN CO ADMINISTERED WITH ATORVASTATIN FOR THE TREATMENT OF CARDIAC RISK. Journal of Critical Reviews, 1 (1), 25-28.